Last update 20 Mar 2025

Shuangshen Yigan Dropping Pills

Overview

Basic Info

Drug Type
Herbal medicine
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Infectious DiseasesDigestive System DisordersHemic and Lymphatic Diseases+ [1]
Active Indication-
Inactive Indication
Acute hepatitis BEcchymosisFeeding and Eating Disorders+ [1]
Originator Organization-
Active Organization-
Inactive Organization
Heilongjiang Kuihua Pharmaceutical Co. Ltd.Heilongjiang Kuihua Pharmaceutical Co. Ltd.
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Shuangshen Yigan Dropping Pills
CTR20130702
/ CompletedPhase 2
双参乙肝滴丸治疗慢性乙型肝炎抗病毒保肝效果和安全性随机双剂量与阳性药对照平行开放多中心IIb期临床试验
[Translation] A randomized double-dose and positive drug-controlled parallel open multicenter phase IIb clinical trial on the antiviral and liver-protective effects and safety of Shuangshen Yigan Drop Pills in the treatment of chronic hepatitis B
CTR20132318
/ CompletedPhase 2
双参乙肝滴丸治疗慢性乙型肝炎的抗病毒保肝效果和安全性
[Translation] Antiviral and liver-protective effects and safety of Shuangshen Yigan Dropping Pills in the treatment of chronic hepatitis B
100 Clinical Results associated with Shuangshen Yigan Dropping Pills
Login to view more data
100 Translational Medicine associated with Shuangshen Yigan Dropping Pills
Login to view more data
100 Patents (Medical) associated with Shuangshen Yigan Dropping Pills
Login to view more data
100 Deals associated with Shuangshen Yigan Dropping Pills
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute hepatitis BPhase 2
China
Heilongjiang Kuihua Pharmaceutical Co. Ltd.Heilongjiang Kuihua Pharmaceutical Co. Ltd.
23 Oct 2005
EcchymosisPhase 2
China
Heilongjiang Kuihua Pharmaceutical Co. Ltd.Heilongjiang Kuihua Pharmaceutical Co. Ltd.
23 Oct 2005
Feeding and Eating DisordersPhase 2
China
Heilongjiang Kuihua Pharmaceutical Co. Ltd.Heilongjiang Kuihua Pharmaceutical Co. Ltd.
23 Oct 2005
Hepatitis B, ChronicPhase 2
China
Heilongjiang Kuihua Pharmaceutical Co. Ltd.Heilongjiang Kuihua Pharmaceutical Co. Ltd.
23 Oct 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free